Abstract:Abstract Background While the COVID-19 pandemic seemed far from the end, the booster vaccine project was proposed to further reduce the transmission risk and infections. However, handful studies have focused on questions that with limited vaccine capacity ether boosting high-risk workers first or prioritizing susceptible normal individuals is optimal, and vaccinating how many people can lead us to the goal of herd immunity. In this study we aimed to explore the conclusions of such two problems with consideration of non-pharmacological interventions including mandatory quarantine for international entrants, keeping social distance and wearing masks. Methods By implementing the corresponding proportion of individuals who remain infectious after four lengths of quarantine strategies to the novel population-stratified model, we quantified the impact of such measures on optimizing vaccine prioritization between high-risk workers and normal populations. Furthermore, by setting the hypothetical COVID-19 transmission severity (reproduction number, R 0 ) to the level of the most contagious COVID-19 variant (B.1.617.2, delta variant, R 0 = 5.0), we separately estimated the threshold vaccine coverage of five countries (China, United States, India, South Africa and Brazil) to reach herd immunity, with and without the consideration of interventions including wearings masks and keeping social distance. At last, the sensitive analysis of essential parameter settings was performed to examine the robustness of conclusions. Results For Chinese scenarios considered with moderate hypothetical transmission rate ( R 0 = 1.15–1.8), prioritizing high-risk workers the booster dose reached lower cumulative infections and deaths if at least 7-days of quarantine for international travelers is maintained, and the required screening time to remain such vaccinating strategy as optimal increased from 7-days to 21-days with the transmission severity. Although simply maintaining at least 7-days quarantine can lead to over 69.12% reduction in total infections, the improvement of longer quarantine strategies was becoming minimum and the least one was 2.28% between the 21 and the 28-days of quarantine. Besides, without the vaccination program, the impact of such measures on transmission control dropped significantly when R 0 exceeded 1.5 and reached its minimal level when R 0 equal to 2.5. On the other hand, when we combat the delta variant, the threshold vaccine coverage of total population to reach herd immunity lay within 74%–89% (corresponding to the vaccine efficiency from 70% to 50%), and such range decreased to 71%–84% if interventions including wearing mask and keeping social distance were implemented. Furthermore, Results of other countries with 85% vaccine efficiency were estimated at 79%, 91%, 94% and 96% for South Africa, Brazil, India and United States respectively. Conclusions Non-pharmacological interventions can substantially affect booster vaccination prioritization and the threshold condition to reach herd immunity. To combat the delta variant, restrictions need to be integrated with mass vaccination so that can reduce the transmission to the minimum level, and the 21-days might be the suggested maximum quarantine duration according to the cost-effectiveness. Besides, by implementing interventions, the requirement to reach herd immunity can be lower in all countries. Lastly, the following surveillance after vaccination can help ensure the real-time proportion of vaccinated individuals with sufficient protection.

Modeling COVID-19 vaccine-induced immunological memory development and its links to antibody level and infectiousness

Modeling how antibody responses may determine the efficacy of COVID-19 vaccines

A mathematical model simulating the adaptive immune response in various vaccines and vaccination strategies

Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint

Dynamical Modelling of Viral Infection and Cooperative Immune Protection in COVID-19 Patients.

Modeling the Impact of Vaccination on COVID-19 and Its Delta and Omicron Variants.

A community study of neutralizing antibodies against SARS-CoV-2 in China

Effect of Vaccination to COVID-19 Disease Progression and Herd Immunity

Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China

A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protection

Antibody Persistence and Risk of COVID-19 Infection: Insights from Modeling

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

Modeling and prediction of COVID-19 in the United States considering population behavior and vaccination

Mechanistic modeling projections of antibody persistence after homologous booster regimens of COVID-19 vaccine Ad26.COV2.S in humans

Impact of non-pharmacological interventions on COVID-19 boosting vaccine prioritization and vaccine-induced herd immunity: a population-stratified modelling study

COVID-19 adaptive humoral immunity models: weakly neutralizing versus antibody-disease enhancement scenarios

Modelling antibody dynamics in humans after different Ad26.COV2.S vaccination schemes

Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines

A prospective cohort-based artificial intelligence evaluation system for the protective efficacy and immune response of SARS-CoV-2 inactivated vaccines

A prognostic model for SARS-CoV-2 breakthrough infection: Analyzing a prospective cellular immunity cohort